Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
ARB | Ann: Annual Meeting Date and Director Nominations | 11/07/25 | 0 | 66 | |||
|
|||||||
ARB | Ann: ArborGen Holdings Limited - Annual Report FY 2025 | 26/06/25 | 0 | 89 | |||
|
|||||||
ARB | Ann: ArborGen Holdings FY25 Results for year ended 31 March 2025 | 08:59 | 0 | 127 | |||
|
|||||||
ARB | Ann: Completion of Share Buyback Programme | 29/01/25 | 0 | 182 | |||
|
|||||||
ARB | Ann: Notice of on-market share buyback | 29/01/25 | 0 | 173 | |||
|
|||||||
ARB | Ann: Notice of on-market share buyback | 28/01/25 | 0 | 137 | |||
|
|||||||
ARB | Ann: Notice of on-market share buyback | 27/01/25 | 0 | 141 | |||
|
|||||||
ARB | Ann: Notice of on-market share buyback | 23/01/25 | 0 | 140 | |||
|
See All Discussions